School Of Medicine 10
451. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
452. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
453. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
454. A Multicentric Study on Adverse COVID-19 Outcomes Among Pregnant and Nonpregnant Women in Multidisciplinary Hospitals of Kazakhstan
455. COVID-19 online learning challenges: Kazakhstan secondary schools case study
456. Evaluating student satisfaction of terminological apparatus with natural and mathematical textbooks in Kazakhstani schools
457. Characteristics of the Online Market for Anabolic-Androgenic Steroids in Central Asia: A Netnographic Analysis
458. The therapeutic potential of mesenchymal stem cells in the treatment of atherosclerosis
459. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
460. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
461. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
462. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
463. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
464. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
465. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
466. Early Identification of CKD—A Scoping Review of the Global Populations
467. Digital Mapping of Central Asian Foods: Towards a Standardized Visual Atlas for Nutritional Research
468. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
469. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
470. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
471. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
472. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
473. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
474. Involvement of the splicing factor SART1 in the BRCA1-dependent homologous recombination repair of DNA double-strand breaks
475. Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO
476. Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)
477. Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)
478. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
479. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
480. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
481. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
482. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
483. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
484. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
485. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
486. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
487. Diagnosis and classification of optic neuritis
488. Strengthening primary health care in Europe with digital solutions
489. Double-Negative T (DNT) Cells in Patients with Systemic Lupus Erythematosus
490. Natural Killer T (NKT) Cells in Autoimmune Hepatitis: Current Evidence from Basic and Clinical Research.
491. Post-vaccination Functional Somatic Disorder
492. Prevalence of Joint Complaints in Patients with Celiac Disease: A Systematic Review and Meta-Analysis
493. Screening for celiac disease in juvenile idiopathic arthritis
494. (TCRαβ+) Double-Negative T Cells in Type 1 Diabetes Mellitus
495. The Role of HLA in the Association between IgA Deficiency and Celiac Disease
496. DNA and Histone Modifications Identify a Putative Controlling Element (CE) on the X Chromosome of Sciara coprophila
497. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe
498. Retraction note: The effects of sildenafil citrate on intrauterine growth restriction: a systematic review and meta-analysis (BMC Pregnancy and Childbirth, (2023), 23, 1, (409), 10.1186/s12884-023-05747-7)
499. The effects of sildenafil citrate on intrauterine growth restriction: a systematic review and meta-analysis
500. Self-Sampling Modality for Cervical Cancer Screening: Overview of the Diagnostic Approaches and Sampling Devices
1 8 9 10 11 12 15